ArticleCureus2025
Cardiac Stereotactic Body Radiation Therapy (SBRT) for Refractory Ventricular Tachycardia Using Innovative Motion Tracking With Electroanatomical Mapping and CyberKnife Synchrony.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- STAR in a Second: Ultra-High-Dose-Rate Spread-Out Bragg Peak Proton Therapy for Breath-Hold Stereotactic Arrhythmia Radioablation.Advances in radiation oncology · 2026Article
- Stereotactic Body Radiotherapy for Refractory Ventricular Tachycardia: From Serendipity to Precision Biological Ablation.Reviews in cardiovascular medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ventricular tachycardia (VT) is a potentially fatal arrhythmia that often requires a combination of medications and invasive procedures, including implantable cardioverter defibrillators (ICDs) and radiofrequency catheter ablation, to manage and treat. Despite these interventions, recurrence rates for VT remain high, particularly in patients with structural heart disease. Recent advancements in cardiac stereotactic body radiation therapy (SBRT) offer a promising alternative for patients with refractory VT, particularly for those whose arrhythmogenic areas are difficult to access through conventional methods. This study presents a novel approach to treating refractory VT, integrating advanced cardiorespiratory motion tracking using CyberKnife Synchrony (Accuray Incorporated, Madison, WI, USA) and a 3D heart reconstruction technology (inHeart, Pessac, France). The case involves a 66-year-old male with a history of dilated cardiomyopathy and recurrent VT, unresponsive to multiple medical and invasive interventions, including ICD implantation and catheter ablation. Using a combination of CT imaging, MRI, and electroanatomical mapping, we identified the arrhythmogenic region of the heart. He then underwent a single fraction of SBRT, 25 Gy to the target area, using real-time motion tracking via Synchrony. Six months post-treatment, the patient remained free from VT and has not required ICD therapies or further medical or procedural interventions. Our center has successfully implemented cardiac SBRT for refractory VT using inHeart technology for heart reconstruction and Synchrony for cardiorespiratory motion tracking.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.